Skip to main content
Screener/Healthcare/Biotechnology

TGTX — TG Therapeutics, Inc.

NASDAQ
$53.76-0.66 (-1.21%)
Mid CapHealthcareFastest GrowingHigh BetaHigh ROE
$25.28
$57.38
$52.70
$55.52
EPS (TTM)$2.86
P/E Ratio19.27
Dividend Yield—
Market Cap$7.88B
Volume1.45M
Prev Close$54.40
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$204.9M$19.8M$0.1283.6%9.7%
Q4 '25$192.6M$23.0M$0.1480.2%12.0%
Q3 '25$161.7M$390.9M$2.4382.6%241.7%
Q2 '25$141.1M$28.2M$0.1786.6%20.0%
Q1 '25$120.9M$5.1M$0.0387.1%4.2%
Q4 '24$108.2M$23.3M$0.1585.8%21.6%
Q3 '24$83.9M$3.9M$0.0288.9%4.6%
Q2 '24$73.5M$6.9M$0.0488.7%9.4%
Get Your Daily Market Recap